Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. / Janson, Eva Tiensuu; Knigge, Ulrich; Dam, Gitte; Federspiel, Birgitte; Grønbaek, Henning; Stålberg, Peter; Langer, Seppo W.; Kjaer, Andreas; Arola, Johanna; Schalin-Jäntti, Camilla; Sundin, Anders; Welin, Staffan; Thiis-Evensen, Espen; Sorbye, Halfdan.
In: Acta Oncologica, Vol. 60, No. 7, 2021, p. 931-941.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
AU - Janson, Eva Tiensuu
AU - Knigge, Ulrich
AU - Dam, Gitte
AU - Federspiel, Birgitte
AU - Grønbaek, Henning
AU - Stålberg, Peter
AU - Langer, Seppo W.
AU - Kjaer, Andreas
AU - Arola, Johanna
AU - Schalin-Jäntti, Camilla
AU - Sundin, Anders
AU - Welin, Staffan
AU - Thiis-Evensen, Espen
AU - Sorbye, Halfdan
N1 - Publisher Copyright: © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2021
Y1 - 2021
N2 - BACKGROUND: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.AIM: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.
AB - BACKGROUND: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.AIM: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.
KW - Diagnosis
KW - neuroendocrine carcinoma
KW - neuroendocrine tumour
KW - treatment
U2 - 10.1080/0284186X.2021.1921262
DO - 10.1080/0284186X.2021.1921262
M3 - Journal article
C2 - 33999752
VL - 60
SP - 931
EP - 941
JO - Acta Oncologica
JF - Acta Oncologica
SN - 1100-1704
IS - 7
ER -
ID: 262914043